Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Are The Forecasted Market Size Estimates For The Critical Limb Ischemia Market Between 2025 And 2029?
The critical limb ischemia market size has experienced significant growth in recent years. It is projected to expand from $3.6 billion in 2024 to $3.89 billion in 2025, achieving a compound annual growth rate (CAGR) of 8.0%. The expansion observed in the historic period can be attributed to a rise in diabetes cases, tobacco consumption, and hypertension prevalence, alongside improvements in vascular imaging, an increase in endovascular interventions, and ongoing medical research and clinical trials.
The market size for critical limb ischemia is anticipated to expand robustly over the next few years. It is projected to achieve $5.52 billion by 2029, growing at a compound annual growth rate (CAGR) of 9.2%. This market expansion during the forecast period is attributable to progress in regenerative medicine, an increased focus on early intervention, the rising prevalence of obesity, global health initiatives, and patient education programs. Significant trends anticipated within this period include wearable health technologies, telemedicine and remote patient monitoring, the integration of artificial intelligence (AI), patient-centric care models, and minimally invasive interventions.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9859&type=smp
Which Factors And Drivers Are Influencing The Critical Limb Ischemia Market In 2025?
The increasing occurrence of diabetes mellitus and peripheral artery diseases is anticipated to drive the expansion of the critical limb ischemia treatment market in the future. Diabetes mellitus is a metabolic disorder characterized by high blood glucose concentrations. Peripheral artery disease describes a state where the arteries in the legs narrow, thereby diminishing blood supply to the arms or legs. Both diabetes and peripheral artery diseases elevate the risk of vascular complications and amputations, positioning them as significant risk factors for developing critical limb ischemia. Consequently, the growing prevalence of diabetes mellitus and peripheral artery diseases is fueling the development of the critical limb ischemia market. For example, data from January 2022 by the International Diabetes Federation, a Belgium-based umbrella organization representing national diabetes associations, projects a global diabetes prevalence rise of 12.2% (totaling 783.2 million people) by 2045. Moreover, a March 2023 publication from the journal by Oxford University Press, a UK-based university press affiliated with the University of Oxford, indicates that the number of individuals affected by peripheral artery diseases is predicted to surge by almost 50% by 2045. Consequently, the increasing embrace of cloud-based document processing services is propelling the critical limb ischemia treatment market.
What Are The Major Segment Types Covered In The Critical Limb Ischemia Market?
The critical limb ischemiamarket covered in this report is segmented –
1) By Type: Devices; Drugs; Surgery
2) By Medication: Antihypertensive Agents; Antiplatelet Drugs; Antithrombotic Agents; Other Medications
3) By Application: Hospital; Clinic; Other Applications
Subsegments:
1) By Devices: Angioplasty Balloons; Stents; Catheters; Atherectomy Devices; Implantable Devices
2) By Drugs: Antiplatelet Agents; Vasodilators; Anticoagulants; Thrombolytics; Growth Factors And Cytokines
3) By Surgery: Bypass Surgery; Endarterectomy; Amputation; Revascularization Procedures
What Key Innovation Trends Are Fueling Advancements In The Critical Limb Ischemia Market?
Major companies in the critical limb ischemia (CLI) treatment market are developing technologically advanced products, such as dissolving stents, to enhance patient outcomes for this severe form of peripheral artery disease. These dissolving stents, also known as bioresorbable stents, are engineered to offer temporary support to the affected artery and then progressively dissolve once the vessel has healed. As an illustration, in April 2024, Abbott Laboratories, a US-based medical device company, secured approval from the Food and Drug Administration (FDA), a US-based federal agency, for the Esprit BTK Everolimus Eluting Resorbable Scaffold System. This is a dissolving stent specifically designed for patients experiencing chronic limb-threatening ischemia (CLTI) in arteries located below the knee. This achievement signifies the first approval for a dissolving stent tailored to this specific condition within the United States. The stent is fabricated from materials similar to those used in dissolving sutures and is intended to gradually dissolve over approximately three years post-implantation. It releases the immunosuppressive drug everolimus, which contributes to preventing arterial re-narrowing and supports vessel recovery.
Which Global Market Leaders Are Shaping The Future Of The Critical Limb Ischemia Sector?
Major companies operating in the critical limb ischemia market include Medtronic Plc, Boston Scientific Corporation, ThermoGenesis Holdings Inc., Abbott Laboratories, Pluri Biotech Ltd., Rexgenero Ltd., LimFlow SA, Micro Medical Solutions, Cardiovascular Systems Inc., Cynata Therapeutics Ltd, Shanghai MicroPort Medical (Group) Co Ltd., B. Braun SE, Teva Pharmaceutical Industries Ltd., Aldagen Inc., Cook Medical, Philips, BD, Penumbra Inc., Cardinal Health Inc., Teleflex Incorporated, AngioDynamics Inc., Endologix Inc., Terumo Corporation, Teleflex, MicroPort Scientific, Silk Road Medical, LeMaitre Vascular Inc., Merit Medical Systems Inc., Shockwave Medical, Avinger, Biomerics LLC, Intact Vascular Inc., Soundbite Medical Solutions, Bluegrass Vascular Technologies, PQ Bypass, Vasorum Ltd, Rex Medical, Otsuka Medical Devices, Aortica Corporation
Download The Full Report For Exclusive Market Findings:
https://www.thebusinessresearchcompany.com/report/critical-limb-ischemia-global-market-report
Which Region Is Projected To Lead The Critical Limb Ischemia Market During The Forecast Period?
North America was the largest region in the critical limb ischemia treatment market in 2024. The regions covered in the critical limb ischemia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Critical Limb Ischemia Market Report:
https://www.thebusinessresearchcompany.com/customise?id=9859&type=smp
Browse Through More Reports Similar to the Global Critical Limb Ischemia Market 2025, By The Business Research Company
Electronic And Precision Equipment Repair And Maintenance Global Market Report 2025
Research Antibodie And Reagent Global Market Report 2025
Catalyst Fertilizer Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/catalyst-fertilizer-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model